Products
Name |
CAS
No. |
Status |
Ropivacaine
Mesylate |
14252-80-3 |
Pilot |
Ropivacaine
hydrochloride
Monohydrate |
132112-35-7 |
Pilot |
Secoisolariciresinol
Diglucoside |
148244-82-0
|
Pilot |
4-Oxo-fenretinide |
865536-65-8 |
Lab
finish |
Sitafloxacin |
127254-12-0 |
Lab
finish |
Ibudilast |
50847-11-5 |
Pilot |
Ivabradine |
35202-54-1 |
Research |
Dabigatran
Etexilate |
429659-01-8 |
Research |
Ambrisentan |
177036-94-1 |
Research |
Bosentan hydrate |
157212-55-0 |
Research |
| Daptomycin |
103060-53-3 |
Lab
finish |
| Emedastine
difumarate |
115256-11-6 |
Pilot |
| Nimustine
Hydrochloride |
55661-38-6 |
Pilot |
| Pirfenidone |
53179-13-8 |
Research |
| Decitabine |
2353-33-5 |
Research |
| Ceftobiprole |
376653-43-9 |
Research |
Sold for laboratory or
manufacturing purposes
only; not for human,
veterinary, food, or
household use.
This product is offered
for R&D use in accordance
with (i) 35 USC 271(e)+A13(1)
in the U.S.; (ii) Section
69.1 of Japanese Patent
Law in Japan; (iii)
Section 11, No. 2 of
the German Patent Act
of 1981 in Germany;
(iv) Section 60, Paragraph
5b of the U.K. Patents
Act of 1977 in the U.K.;
(v) Section 68B of the
Patents Act of 1953
in New Zealand; (vi)
such related legislation
and/or case law as may
be or become applicable
in the aforementioned
countries; and (vii)
such similar laws and
rules as may apply in
various other countries.
Not available in some
countries; not available
to some institutions;
not available for some
uses.
